RIGHT VENTRICULAR MATRISOME IN HUMAN HEART FAILURE  by Gerard Di Salvo, Thomas et al.
Heart Failure and Cardiomyopathies
A854
JACC April 1, 2014
Volume 63, Issue 12
right ventricular MatriSoMe in huMan heart failure
Poster Contributions
Hall C
Saturday, March 29, 2014, 3:45 p.m.-4:30 p.m.
Session Title: Regulation of Cardiac Fibrosis in Heart Failure
Abstract Category: 13. Heart Failure and Cardiomyopathies: Basic
Presentation Number: 1148-208
Authors: Thomas Gerard Di Salvo, Cristi Galindo, Travis Clark, Yan Guo, Su Yan Ru, Tarek Absi, Simon Maltais, Anna Hemnes, Douglas Sawyer, 
Vanderbilt Heart and Vascular Institute, Nashville, TN, USA
background: The right ventricular (RV) extracellular matrix proteome (“RV matrisome”) has not been widely studied in human heart failure (HF). 
We hypothesized that 1) differential expression of RV matrisome component (MC) expression occurs and that 2) matrisome transcriptional profiling 
might yield novel MCs, pathways/networks for mechanistic study.
Methods: We performed RNAseq (30M target reads/cDNA library, paired-end 50 bp sequencing by Illumina HiSeq 25009) on 5 unused donor RVs 
(DON) and 22 explanted HF RVs. We used a sum of ranks approach across three analytic platforms (DESeq, edgeR and baySeq) to detect log2fold 
(L2F) changes and differentially expressed genes (DEGs, adjusted p < 0.05) between DON and HF RVs and used Ingenuity for pathway and network 
analysis.
results: We identified RV matrisome DEGs (Table) after review of published inventories of MCs.
MC Group MCs Reviewed DEGs Most significant DEGs
Glycoproteins 200 24
↑ MXRA5, FNDC1, CRISPLD1, CYR61, SMOC2, NTNG2, THBS4
↓ WISP1, SPP1, MMRN1, MATN3, MFAP5, BMPER, SPARCL1, NID1, LAMA3, -A5
Collagens 35 7
↑ COL9A1, -22A1, -14A1, -16A1
↓ COL4A3, -6A3, -27A1
Proteoglycans 36 4
↑ ESMI, OGN, LUM
↓ SRGN
Affiliated proteins 275 8
↑ LGALS9
↓ FNC3, CLEC7A, ANXA3, -2P2, CIQB, -QC
Regulators 252 22
↑ HYAL4, LEPREL1, ADAMTSL1, HABP2, ADAM19, HTRA1, IHIH5
↓ SERPINA3, -A5, F13A1, ADAMTS5, -ST2 TIMP4, ELANE, CPAMD8, HPSE
Secreted Factors 451 22
↑ FGF23, IL10, CSF3, CCL3, SFRP4, ANGPTL4, TGFB2, SCUBE2, CCL5, FRZB
↓ FGF10, S100A9, -A8, -A4, WIF1,MDK, CRLF1, LEFTY2, TPO, WNT9B, FGF7
↑ = increased expression; ↓ = decreased expression
The top canonical pathway was “differential regulation of cytokine production” and top network “tissue development, cellular movement, 
hematological system development/function” with predicted upstream regulatory inhibition of TGFB1, CTNNB1, FGFR2 and CEBPA and upstream 
regulatory activation of ERBB2 and ERBB4.
conclusion: RNAseq identifies differential expression of RV matrisome glycoproteins, collagens, proteoglycans, affiliated proteins, regulators and 
secreted factors and implicates important regulatory roles for cytokine and ERBB2/4signaling.
